Earlier this month, a decision from the Office of Inspector General (OIG) offered noteworthy insight to employed physicians. OIG issued Advisory Opinion 23-07, in which the federal body considered an employer’s proposition to pay bonuses to its employed physicians. These proposed bonuses were to be awarded on the basis of net profits arising from select procedures carried out by the doctors.
While such a compensation scheme has the potential to implicate the federal Anti-Kickback Statute (AKS), in this particular instance, OIG found that the proposed arrangement could luxuriate under the haven of a statutory exception. This decision thereby presents a favorable conclusion for employers harboring ambitions toward similar compensation models that might previously have trod uncomfortably close to territory demarcated by the AKS.
The full details regarding the particular case are laid out in Advisory Opinion 23-07.
The context for this development tracks back to the AKS, a piece of federal law intended to constrain illicit financial incentives within the healthcare sector. Envisaged by this law is the protection of patients and the federal health care programs from fraud and abuse by curtailing the corrupt influence of money on healthcare decisions. Any remunerative transactions intending to induce or reward referrals of business payable by a federal health care program is strictly proscribed by the statute. Entities that defy the AKS face hefty penalties, placing them in ongoing legal and financial jeopardy.
This recent advisory opinion by the OIG, however, emphasizes that not all employer bonus structures would be considered kickbacks under the AKS. Indeed, in this case, the proposal highlighted net profits arising from specific procedures conducted by the physicians, rather than profits generated from referrals. Consequently, the OIG concluded that while the proposed remuneration system implicated the AKS, it also fell under an AKS statutory exception, thereby circumventing any potential legal conflict. It underscores the importance for corporations and law firms navigating these legal waters to pay close attention to the nuances within the AKS and its statutory exceptions.
JDSupra’s original article, as well as Advisory Opinion 23-07 itself, provide greater detail and reinforce the OIG’s mandate to uphold the integrity of the healthcare system, whilst allowing flexibility for innovative compensation models within the statutory boundaries.